FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic ... | 合法藥品大搜索

Read More

由 T Conroy 著作 · 2011 · 被引用 5483 次 — FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer and good performance status. (Funded by the French ... Read More

由 L Cavanna 著作 · 2019 · 被引用 8 次 — Purpose: Metastatic pancreatic adenocarcinoma has a very poor prognosis. Although irinotecan, oxaliplatin and leucovorin-modulated ... Read More

由 F Yang 著作 · 2019 · 被引用 4 次 — The modified FOLFIRINOX regimen is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer, and should be a new standard of care for this ... Read More

If you have cancer that can be removed with surgery (such as the Whipple's procedure), you may be offered FOLFIRINOX after surgery to try stop the cancer ... Read More

由 JD Mizrahi 著作 · 2020 · 被引用 16 次 — Background: Although FOLFIRINOX (5-Fluorouracil + leucovorin + irinotecan + oxaliplatin) is now the standard of care for patients (pts) with metastatic ... Read More

由 T Conroy 著作 · 2018 · 被引用 839 次 — Adjuvant therapy with a modified FOLFIRINOX regimen led to ... than gemcitabine among patients with resected pancreatic cancer, at the ... Read More

由 RDW Marsh 著作 · 2015 · 被引用 48 次 — FOLFIRINOX (FFX) was introduced to clinical practice in 2010 following publication of the PRODIGE 4/ACCORD 11 study, which compared this ... Read More

Cycle length: 14 days. Drug, Dose and route, Administration, Given on days. Oxaliplatin*, 85 mg/m2 IV, Dilute in 500 mL D5W¶ and administer over two hours​ ... Read More

2020年7月15日 — FOLFIRINOX appeared more active than gemcitabine plus nab-paclitaxel (​Abraxane) as an upfront treatment for localized pancreatic cancer, ... Read More